RESUMO
BACKGROUND: The risk of neural tube defects (NTDs) is influenced by nutritional factors and genetic determinants of one-carbon metabolism. A key pathway of this metabolism is the vitamin B-12- and folate-dependent remethylation of homocysteine, which depends on methionine synthase (MS, encoded by MTR), methionine synthase reductase, and methylenetetrahydrofolate reductase. Methionine, the product of this pathway, is the direct precursor of S-adenosylmethionine (SAM), the universal methyl donor needed for epigenetic mechanisms. OBJECTIVES: This study aimed to evaluate whether the availability of vitamin B-12 and folate and the expression or activity of the target enzymes of the remethylation pathway are involved in NTD risk. METHODS: We studied folate and vitamin B-12 concentrations and activity, expression, and gene variants of the 3 enzymes in liver from 14 NTD and 16 non-NTD fetuses. We replicated the main findings in cord blood from pregnancies of 41 NTD fetuses compared with 21 fetuses with polymalformations (metabolic and genetic findings) and 375 control pregnancies (genetic findings). RESULTS: The tissue concentration of vitamin B-12 (P = 0.003), but not folate, and the activity (P = 0.001), transcriptional level (P = 0.016), and protein expression (P = 0.003) of MS were decreased and the truncated inactive isoforms of MS were increased in NTD livers. SAM was significantly correlated with MS activity and vitamin B-12. A gene variant in exon 1 of GIF (Gastric Intrinsic Factor gene) was associated with a dramatic decrease of liver vitamin B-12 in 2 cases. We confirmed the decreased vitamin B-12 in cord blood from NTD pregnancies. A gene variant of GIF exon 3 was associated with NTD risk. CONCLUSIONS: The decreased vitamin B-12 in liver and cord blood and decreased expression and activity of MS in liver point out the impaired remethylation pathway as hallmarks associated with NTD risk. We suggest evaluating vitamin B-12 in the nutritional recommendations for prevention of NTD risk beside folate fortification or supplementation.
Assuntos
5-Metiltetra-Hidrofolato-Homocisteína S-Metiltransferase/genética , Doenças Fetais/enzimologia , Fígado/metabolismo , Defeitos do Tubo Neural/enzimologia , Vitamina B 12/metabolismo , 5-Metiltetra-Hidrofolato-Homocisteína S-Metiltransferase/metabolismo , Estudos de Casos e Controles , Feminino , Ferredoxina-NADP Redutase/genética , Ferredoxina-NADP Redutase/metabolismo , Doenças Fetais/genética , Doenças Fetais/metabolismo , Ácido Fólico/análise , Ácido Fólico/metabolismo , Idade Gestacional , Humanos , Fígado/química , Fígado/embriologia , Fígado/enzimologia , Masculino , Metilenotetra-Hidrofolato Redutase (NADPH2)/genética , Metilenotetra-Hidrofolato Redutase (NADPH2)/metabolismo , Defeitos do Tubo Neural/embriologia , Defeitos do Tubo Neural/genética , Defeitos do Tubo Neural/metabolismo , Gravidez , Vitamina B 12/análiseAssuntos
Doenças Fetais/genética , Doenças Fetais/terapia , Terapia Genética/métodos , Terapia Genética/tendências , Cuidado Pré-Natal/tendências , Animais , Feminino , Doenças Fetais/enzimologia , Retardo do Crescimento Fetal/genética , Retardo do Crescimento Fetal/terapia , Doença de Gaucher/enzimologia , Doença de Gaucher/genética , Doença de Gaucher/terapia , Terapia Genética/ética , Glucosilceramidase/genética , Glucosilceramidase/metabolismo , Humanos , Camundongos , Gravidez , Cuidado Pré-Natal/éticaRESUMO
Acute fatty liver of pregnancy (AFLP) is an obstetric emergency characterized by maternal liver failure and may have complications for the mother and fetus, including death. This review examines recent literature on the epidemiology, pathogenesis, diagnosis, and treatment of acute fatty liver of pregnancy. Pathogenesis of this disease has been linked to defects in fatty acid metabolism during pregnancy, especially in the setting of fetal genetic defects in fatty acid oxidation. The value of screening all patients for these genetic defects remains to be determined. Distinguishing AFLP from other high-risk liver diseases of pregnancy that have overlap features, such as HELLP and preeclampsia, can be challenging. Although sensitive diagnostic tools such as the Swansea criteria have been developed, further work is needed to diagnose AFLP more quickly. Although survival rates have improved in the past 30 years, delay in diagnosis and treatment of AFLP has life-threatening consequences; an algorithmic approach to AFLP may be a valuable resource for clinicians. Future epidemiological and long-term studies will improve our prediction of women at risk for developing AFLP and determine the long-term consequences of this condition.
Assuntos
3-Hidroxiacil-CoA Desidrogenase/deficiência , Fígado Gorduroso/diagnóstico , Fígado Gorduroso/genética , Doenças Fetais/fisiopatologia , Complicações na Gravidez/diagnóstico , Complicações na Gravidez/genética , 3-Hidroxiacil-CoA Desidrogenase/genética , Doença Aguda , Diagnóstico Diferencial , Fígado Gorduroso/epidemiologia , Fígado Gorduroso/terapia , Feminino , Doenças Fetais/diagnóstico , Doenças Fetais/enzimologia , Humanos , Falência Hepática Aguda/etiologia , Gravidez , Complicações na Gravidez/epidemiologia , Complicações na Gravidez/terapia , Fatores de RiscoRESUMO
Glucococorticoids play a critical role in the developmental programing and fetal growth. Key molecules mediating and regulating tissue-specific glucocorticoid actions are 11beta-hydroxysteroid dehydrogenase (11beta-HSD) type 1 and 2 isozymes, both of which are expressed in the placenta and the fetal membranes. 11beta-HSD1 is implicated in the pathogenesis of metabolic syndrome and its dysregulation has been observed in pregnancy-related complications (pre-eclampsia, intrauterine growth restriction). Interestingly, preliminary clinical data have associated certain 11beta-HSD1 gene polymorphisms with hypertensive disorders in pregnancy, suggesting, if confirmed by further targeted studies, it's potential as a putative prognostic marker. Animal studies and observations in humans have confirmed that 11beta-HSD2 insufficiency is related with pregnancy adversity (pre-eclampsia, intrauterine growth restriction, preterm birth). Importantly, down-regulation or deficiency of placental 11beta-HSD2 is associated with significant restriction in fetal growth and low-birth weight, and unfavorable cardio-metabolic profile in adulthood. The potential association of 11beta-HSD1 tissue-specific dysregulation with gestational diabetes, as well as the plausible utility of 11beta-HSD2, as a biomarker of pregnancy adversity and later life morbidity, are emerging areas of intense scientific interest and future investigation.
Assuntos
11-beta-Hidroxiesteroide Desidrogenase Tipo 1/metabolismo , 11-beta-Hidroxiesteroide Desidrogenase Tipo 2/metabolismo , Doenças Fetais/enzimologia , Complicações na Gravidez/enzimologia , 11-beta-Hidroxiesteroide Desidrogenase Tipo 1/genética , 11-beta-Hidroxiesteroide Desidrogenase Tipo 2/genética , Regulação para Baixo , Epigênese Genética , Feminino , Doenças Fetais/genética , Humanos , Placenta/enzimologia , Polimorfismo Genético , Gravidez , Complicações na Gravidez/genética , Efeitos Tardios da Exposição Pré-Natal/enzimologia , Efeitos Tardios da Exposição Pré-Natal/genéticaRESUMO
OBJECTIVES: There is growing evidence of ongoing, in utero neurological damage in fetuses with myelomeningocele (MMC). Phospholipase A2 (PLA2) has known neurotoxic properties and is predominantly present in its secretory isoform (sPLA2) in meconium, the passage of which is increased in MMC fetuses. The objective of this study was to determine if amniotic fluid (AF) levels of PLA2 are elevated in a rat model of MMC. METHODS: Timed pregnant Sprague-Dawley rats were gavage fed 60 mg/kg/bodyweight retinoic acid (RA) in olive oil at embryonic day 10 (E10). Amniocentesis was performed at multiple gestational time points on MMC fetuses, RA-exposed fetuses without MMC and control fetuses. AF PLA2 levels were analyzed by a fluorescent enzyme activity assay. PLA2 isoforms were determined by measuring activity in the presence of specific inhibitors. RESULTS: There was no difference in AF PLA2 activity between groups on E15. PLA2 activity was significantly increased in MMC fetuses on E17, E19 and E21 (p < 0.001). Secretory PLA2 primarily accounted for the overall greater activity. CONCLUSIONS: PLA2 levels are elevated in the AF of fetal rats with MMC and may contribute to ongoing neural injury. This pathway may be a useful drug target to limit ongoing damage and better preserve neurologic function.
Assuntos
Líquido Amniótico/enzimologia , Doenças Fetais/enzimologia , Meningomielocele/enzimologia , Fosfolipases A2 Secretórias/metabolismo , Animais , Modelos Animais de Doenças , Feminino , Doenças Fetais/induzido quimicamente , Imunofluorescência , Isoenzimas/metabolismo , Meningomielocele/induzido quimicamente , Gravidez , Ratos , Ratos Sprague-Dawley , TretinoínaRESUMO
Striated preferentially expressed gene (Speg) is a member of the myosin light chain kinase family. We previously showed that disruption of the Speg gene locus in mice leads to a dilated cardiomyopathy with immature-appearing cardiomyocytes. Here we show that cardiomyopathy of Speg(-/-) mice arises as a consequence of defects in cardiac progenitor cell (CPC) function, and that neonatal cardiac dysfunction can be rescued by in utero injections of wild-type CPCs into Speg(-/-) foetal hearts. CPCs harvested from Speg(-/-) mice display defects in clone formation, growth and differentiation into cardiomyocytes in vitro, which are associated with cardiac dysfunction in vivo. In utero administration of wild-type CPCs into the hearts of Speg(-/-) mice results in CPC engraftment, differentiation and myocardial maturation, which rescues Speg(-/-) mice from neonatal heart failure and increases the number of live births by fivefold. We propose that in utero administration of CPCs may have future implications for treatment of neonatal heart diseases.
Assuntos
Cardiomiopatias/terapia , Terapia Baseada em Transplante de Células e Tecidos , Doenças Fetais/terapia , Terapias Fetais , Miócitos Cardíacos/transplante , Animais , Cardiomiopatias/embriologia , Cardiomiopatias/enzimologia , Cardiomiopatias/fisiopatologia , Diferenciação Celular , Feminino , Doenças Fetais/enzimologia , Doenças Fetais/genética , Doenças Fetais/fisiopatologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Proteínas Musculares/genética , Proteínas Musculares/metabolismo , Miócitos Cardíacos/citologia , Miócitos Cardíacos/enzimologia , Quinase de Cadeia Leve de Miosina/genética , Quinase de Cadeia Leve de Miosina/metabolismo , Gravidez , Transplante de Células-Tronco , Células-Tronco/citologia , Células-Tronco/enzimologia , ÚteroRESUMO
Polymicrogyria (PMG) is a structural brain abnormality involving the cerebral cortex that results from impaired neuronal migration and although several genes have been implicated, many cases remain unsolved. In this study, exome sequencing in a family where three fetuses had all been diagnosed with PMG and cerebellar hypoplasia allowed us to identify regions of the genome for which both chromosomes were shared identical-by-descent, reducing the search space for causative variants to 8.6% of the genome. In these regions, the only plausibly pathogenic mutations were compound heterozygous variants in PI4KA, which Sanger sequencing confirmed segregated consistent with autosomal recessive inheritance. The paternally transmitted variant predicted a premature stop mutation (c.2386C>T; p.R796X), whereas the maternally transmitted variant predicted a missense substitution (c.5560G>A; p.D1854N) at a conserved residue within the catalytic domain. Functional studies using expressed wild-type or mutant PI4KA enzyme confirmed the importance of p.D1854 for kinase activity. Our results emphasize the importance of phosphoinositide signalling in early brain development.
Assuntos
Artrogripose/enzimologia , Cerebelo/anormalidades , Doenças Fetais/enzimologia , Mutação em Linhagem Germinativa , Malformações do Sistema Nervoso/enzimologia , Fosfotransferases (Aceptor do Grupo Álcool)/genética , Polimicrogiria/enzimologia , Sequência de Aminoácidos , Artrogripose/embriologia , Artrogripose/genética , Sequência de Bases , Encéfalo/embriologia , Encéfalo/enzimologia , Cerebelo/embriologia , Cerebelo/enzimologia , Deficiências do Desenvolvimento/enzimologia , Deficiências do Desenvolvimento/genética , Exoma , Feminino , Doenças Fetais/genética , Humanos , Lactente , Masculino , Antígenos de Histocompatibilidade Menor , Dados de Sequência Molecular , Mutação de Sentido Incorreto , Malformações do Sistema Nervoso/embriologia , Malformações do Sistema Nervoso/genética , Linhagem , Fosfotransferases (Aceptor do Grupo Álcool)/química , Polimicrogiria/embriologia , Polimicrogiria/genética , Polimorfismo de Nucleotídeo Único , Alinhamento de SequênciaRESUMO
OBJECTIVE: To characterize the mutation spectrum of phenylalanine hydroxylase (PAH) gene and perform prenatal diagnosis for families with classical phenylketonuria. METHODS: By stratified sequencing, mutations were detected in the exons and flaking introns of PAH gene of 44 families with classical phenylketonuria. 47 fetuses were diagnosed by combined sequencing with linkage analysis of three common short tandem repeats (STR) (PAH-STR, PAH-26 and PAH-32) in the PAH gene. RESULTS: Thirty-one types of mutations were identified. A total of 84 mutations were identified in 88 alleles (95.45%), in which the most common mutation have been R243Q (21.59%), EX6-96A>G (6.82%), IVS4-1G>A (5.86%) and IVS7+2T>A (5.86%). Most mutations were found in exons 3, 5, 6, 7, 11 and 12. The polymorphism information content (PIC) of these three STR markers was 0.71 (PAH-STR), 0.48 (PAH-26) and 0.40 (PAH-32), respectively. Prenatal diagnosis was performed successfully with the combined method in 47 fetuses of 44 classical phenylketonuria families. Among them, 11 (23.4%) were diagnosed as affected, 24 (51.1%) as carriers, and 12 (25.5%) as unaffected. CONCLUSION: Prenatal diagnosis can be achieved efficiently and accurately by stratified sequencing of PAH gene and linkage analysis of STR for classical phenylketonuria families.
Assuntos
Doenças Fetais/enzimologia , Fenilalanina Hidroxilase/genética , Fenilcetonúrias/diagnóstico , Fenilcetonúrias/enzimologia , Mutação Puntual , Adolescente , Adulto , Estudos de Casos e Controles , Criança , Pré-Escolar , Feminino , Doenças Fetais/diagnóstico , Doenças Fetais/genética , Testes Genéticos , Humanos , Lactente , Recém-Nascido , Masculino , Repetições de Microssatélites , Pessoa de Meia-Idade , Linhagem , Fenilcetonúrias/genética , Gravidez , Diagnóstico Pré-Natal , Adulto JovemAssuntos
Hiperplasia Suprarrenal Congênita/tratamento farmacológico , Anti-Inflamatórios/administração & dosagem , Dexametasona/administração & dosagem , Doenças Fetais/tratamento farmacológico , Hidrocortisona/administração & dosagem , Hiperplasia Suprarrenal Congênita/diagnóstico , Hiperplasia Suprarrenal Congênita/enzimologia , Hiperplasia Suprarrenal Congênita/genética , Adulto , Feminino , Doenças Fetais/diagnóstico , Doenças Fetais/enzimologia , Doenças Fetais/genética , Humanos , Masculino , Gravidez , Diagnóstico Pré-NatalRESUMO
Embryos exposed to high glucose exhibit aberrant maturational and cytoarchitectural cellular changes, implicating cellular organelle stress in diabetic embryopathy. c-Jun-N-terminal kinase 1/2 (JNK1/2) activation is a causal event in maternal diabetes-induced neural tube defects (NTD). However, the relationship between JNK1/2 activation and endoplasmic reticulum (ER) stress in diabetic embryopathy has never been explored. We found that maternal diabetes significantly increased ER stress markers and induced swollen/enlarged ER lumens in embryonic neuroepithelial cells during neurulation. Deletion of either jnk1 or jnk2 gene diminished hyperglycemia-increased ER stress markers and ER chaperone gene expression. In embryos cultured under high-glucose conditions (20 mmol/L), the use of 4-phenylbutyric acid (4-PBA), an ER chemical chaperone, diminished ER stress markers and abolished the activation of JNK1/2 and its downstream transcription factors, caspase 3 and caspase 8, and Sox1 neural progenitor apoptosis. Consequently, both 1 and 2 mmol/L 4-PBA significantly ameliorated high glucose-induced NTD. We conclude that hyperglycemia induces ER stress, which is responsible for the proapoptotic JNK1/2 pathway activation, apoptosis, and NTD induction. Suppressing JNK1/2 activation by either jnk1 or jnk2 gene deletion prevents ER stress. Thus, our study reveals a reciprocal causation of ER stress and JNK1/2 in mediating the teratogenicity of maternal diabetes.
Assuntos
Diabetes Mellitus Experimental/enzimologia , Estresse do Retículo Endoplasmático , Doenças Fetais/enzimologia , Proteína Quinase 8 Ativada por Mitógeno/metabolismo , Proteína Quinase 9 Ativada por Mitógeno/metabolismo , Defeitos do Tubo Neural/prevenção & controle , Gravidez em Diabéticas/enzimologia , Animais , Apoptose/efeitos dos fármacos , Apoptose/fisiologia , Biomarcadores/metabolismo , Caspase 3/metabolismo , Caspase 8/metabolismo , Diabetes Mellitus Experimental/genética , Feminino , Doenças Fetais/tratamento farmacológico , Doenças Fetais/genética , Deleção de Genes , Hiperglicemia/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Proteína Quinase 8 Ativada por Mitógeno/antagonistas & inibidores , Proteína Quinase 8 Ativada por Mitógeno/genética , Proteína Quinase 9 Ativada por Mitógeno/antagonistas & inibidores , Proteína Quinase 9 Ativada por Mitógeno/genética , Chaperonas Moleculares/biossíntese , Defeitos do Tubo Neural/tratamento farmacológico , Defeitos do Tubo Neural/metabolismo , Células Neuroepiteliais/efeitos dos fármacos , Células Neuroepiteliais/metabolismo , Neurulação/efeitos dos fármacos , Neurulação/genética , Neurulação/fisiologia , Fenilbutiratos/farmacologia , Gravidez , Fatores de Transcrição SOXB1/metabolismoRESUMO
Congenital muscular dystrophies due to defects in genes encoding proteins involved in α-dystroglycan (α-DG) glycosylation are a heterogeneous group of muscle disorders variably associated with central nervous system and eye abnormalities. One of the more severe is muscle-eye-brain disease (MEB). Mutations in genes coding for proven or putative glycosyltransferases (POMT1, POMT2, POMGnT1, fukutin, FKRP, and LARGE), the DPM3 gene encoding a DOL-P-Man synthase subunit, and the DAG1 gene encoding α-dystroglycan, have been associated with altered α-DG glycosylation. We report new POMGnT1 mutations and evaluate protein expression in 3 patients and 2 foetuses with variably severe MEB features. We identify two new point mutations (c.643C>T, c.1863delC), one new intragenic rearrangement (deletion of exons 2-8), and a new intron retention (between exons 21 and 22) resulting from a known point mutation c.1895+1G>T. Our study provides further evidence that rearrangements of the POMGnT1 gene are relatively common. Importantly, if heterozygous, they can be missed on standard genomic DNA sequencing. POMGNT1 protein analysis in 3 patients showed that the severity of the phenotype does not correlate with protein expression. Cerebral MRI is important for identifying MEB and α-dystroglycanopathy phenotypes in children and foetuses, and hence for directing the genetic analysis.
Assuntos
Predisposição Genética para Doença/genética , N-Acetilglucosaminiltransferases/genética , N-Acetilglucosaminiltransferases/metabolismo , Síndrome de Walker-Warburg/enzimologia , Síndrome de Walker-Warburg/genética , Adolescente , Criança , Pré-Escolar , Evolução Fatal , Feminino , Doenças Fetais/diagnóstico , Doenças Fetais/enzimologia , Doenças Fetais/genética , Rearranjo Gênico/genética , Humanos , Masculino , Fenótipo , Mutação Puntual/genética , Gravidez , Índice de Gravidade de Doença , Síndrome de Walker-Warburg/diagnósticoRESUMO
We describe the first case of prenatal diagnosis for pyruvate kinase (PK) deficiency in Chinese and emphasize that this disease is an important differential diagnosis in pediatric patients with non-spherocytic hemolytic anemia. A Han Chinese child with a history of severe transfusion-dependent hemolytic anemia was diagnosed to have PK deficiency. Prenatal diagnosis was performed on the second child based on the genetic findings from the family. The index patient was compound heterozygous for a missense mutation (c.1073G > A. p.Gly358Glu) from his father and a large deletion (c.283 + 1914_c.1434del5006) from his mother. The fetus was a simple heterozygote for the paternal mutation. Pregnancy was allowed to continue and a healthy baby was born. Severe PK deficiency warranting prenatal diagnosis is seen in Han Chinese. Genetic characterization and genotype-phenotype correlation studies on PKLR in different populations are indicated to better define the role of prenatal diagnosis in PK deficiency.
Assuntos
Doenças Fetais/genética , Diagnóstico Pré-Natal , Piruvato Quinase/deficiência , Piruvato Quinase/genética , Sequência de Bases , China , Análise Mutacional de DNA , Saúde da Família , Feminino , Doenças Fetais/diagnóstico , Doenças Fetais/enzimologia , Humanos , Recém-Nascido , Masculino , Mutação , Linhagem , GravidezRESUMO
The mechanisms underlying the teratogenicity of methanol (MeOH) in rodents, unlike its acute toxicity in humans, are unclear, but may involve reactive oxygen species (ROS). Embryonic catalase, although expressed at about 5% of maternal activity, may protect the embryo by detoxifying ROS. This hypothesis was investigated in whole embryo culture to remove confounding maternal factors, including metabolism of MeOH by maternal catalase. C57BL/6 (C57) mouse embryos expressing human catalase (hCat) or their wild-type (C57 WT) controls, and C3Ga.Cg-Catb/J acatalasemic (aCat) mouse embryos or their wild-type C3HeB/FeJ (C3H WT) controls, were explanted on gestational day (GD) 9 (plug=GD 1), exposed for 24 h to 4 mg/ml MeOH or vehicle, and evaluated for functional and morphological changes. hCat and C57 WT vehicle-exposed embryos developed normally. MeOH was embryopathic in C57 WT embryos, evidenced by decreases in anterior neuropore closure, somites developed and turning, whereas hCat embryos were protected. Vehicle-exposed aCat mouse embryos had lower yolk sac diameters compared to C3H WT controls, suggesting that endogenous ROS are embryopathic. MeOH was more embryopathic in aCat embryos than WT controls, with reduced anterior neuropore closure and head length only in catalase-deficient embryos. These data suggest that ROS may be involved in the embryopathic mechanism of methanol, and that embryonic catalase activity may be a determinant of teratological risk.
Assuntos
Catalase/biossíntese , Doenças Fetais/enzimologia , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Metanol/toxicidade , Mutação/genética , Acatalasia/enzimologia , Acatalasia/genética , Animais , Catalase/genética , Embrião de Mamíferos , Feminino , Doenças Fetais/induzido quimicamente , Humanos , Camundongos , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , GravidezRESUMO
On February 3, 2010, a "Letter of Concern from Bioethicists," organized by fetaldex.org, was sent to report suspected violations of the ethics of human subjects research in the off-label use of dexamethasone during pregnancy by Dr. Maria New. Copies of this letter were submitted to the FDA Office of Pediatric Therapeutics, the Department of Health and Human Services (DHHS) Office for Human Research Protections, and three universities where Dr. New has held or holds appointments. We provide a critical appraisal of the Letter of Concern and show that it makes false claims, misrepresents scientific publications and websites, fails to meet standards of evidence-based reasoning, makes undocumented claims, treats as settled matters what are, instead, ongoing controversies, offers "mere opinion" as a substitute for argument, and makes contradictory claims. The Letter of Concern is a case study in unethical transgressive bioethics. We call on fetaldex.org to withdraw the letter and for co-signatories to withdraw their approval of it.
Assuntos
Hiperplasia Suprarrenal Congênita/diagnóstico , Hiperplasia Suprarrenal Congênita/tratamento farmacológico , Correspondência como Assunto , Dexametasona/administração & dosagem , Transtornos do Desenvolvimento Sexual/prevenção & controle , Eticistas/normas , Doenças Fetais/tratamento farmacológico , Genitália Feminina/anormalidades , Uso Off-Label , Diagnóstico Pré-Natal , Experimentação Humana Terapêutica/ética , Hiperplasia Suprarrenal Congênita/complicações , Hiperplasia Suprarrenal Congênita/enzimologia , Ensaios Clínicos como Assunto , Transtornos do Desenvolvimento Sexual/etiologia , Esquema de Medicação , Comitês de Ética em Pesquisa , Feminino , Doenças Fetais/diagnóstico , Doenças Fetais/enzimologia , Genitália Feminina/cirurgia , Glucocorticoides/administração & dosagem , Humanos , Consentimento Livre e Esclarecido/ética , Masculino , Uso Off-Label/ética , Gravidez , Procedimentos de Cirurgia Plástica , Encaminhamento e Consulta , Esteroide 21-Hidroxilase/metabolismo , Estados Unidos , United States Food and Drug Administration , Virilismo/prevenção & controleAssuntos
Hiperplasia Suprarrenal Congênita/complicações , Hiperplasia Suprarrenal Congênita/diagnóstico , Dexametasona/administração & dosagem , Transtornos do Desenvolvimento Sexual/prevenção & controle , Doenças Fetais/diagnóstico , Diagnóstico Pré-Natal , Experimentação Humana Terapêutica/ética , Hiperplasia Suprarrenal Congênita/enzimologia , Algoritmos , Transtornos do Desenvolvimento Sexual/etiologia , Esquema de Medicação , Comitês de Ética em Pesquisa , Feminino , Doenças Fetais/enzimologia , Genitália Feminina/cirurgia , Glucocorticoides/administração & dosagem , Humanos , Procedimentos de Cirurgia Plástica , Encaminhamento e Consulta , Esteroide 21-Hidroxilase/metabolismo , Estados Unidos , Virilismo/prevenção & controleRESUMO
BACKGROUND/PURPOSE: We aimed to determine whether the profile of matrix metalloproteinase (MMP) activity in fetal urine correlates with the degree of kidney damage in the setting of congenital obstructive uropathy. METHODS: Fetal lambs underwent either a sham operation or creation of a complete urinary tract obstruction. Necropsies were performed before term, when urinary MMP profiling was performed by zymography; and kidney damage was assessed histologically by multiple semiquantitative analyses and histomorphometric measurements. RESULTS: There was a significant correlation between inner medullary thickness and MMP-9 (P = .005) and 63-kd MMP-2 (P = .019) activities. In like manner, the only MMPs associated with kidney fibrosis were MMP-9 and 63-kd MMP-2. Matrix metalloproteinase-9 activity was a highly significant independent predictor of the total combined kidney fibrosis score (P < .001) as well as of higher fibrosis grades in each of 6 kidney areas analyzed (all with P < .01). The activity of 63-kd MMP-2 correlated significantly with higher fibrosis in select areas. CONCLUSIONS: In a fetal ovine model, urinary MMP activity correlates with the degree of kidney damage. The presence of MMP-9 (in particular) and that of 63-kd MMP-2 are independent predictors of severity. Prenatal urinary MMP profiling may enhance patient stratification and counseling in the setting of congenital obstructive uropathy.
Assuntos
Doenças Fetais/enzimologia , Nefropatias/patologia , Rim/embriologia , Metaloproteinase 2 da Matriz/urina , Metaloproteinase 9 da Matriz/urina , Prenhez , Obstrução Ureteral/enzimologia , Animais , Biomarcadores/urina , Modelos Animais de Doenças , Progressão da Doença , Feminino , Doenças Fetais/patologia , Fibrose , Nefropatias/congênito , Nefropatias/urina , Gravidez , Diagnóstico Pré-Natal , Índice de Gravidade de Doença , Ovinos , Obstrução Ureteral/congênito , Obstrução Ureteral/embriologiaRESUMO
To address the role of PKC isoforms in hyperglycemia-induced apoptosis and malformations in the embryos of diabetic pregnancies, expression of PKCalpha, beta1, beta 2, gamma, delta, epsilon, and zeta was examined in the neural tube of rat embryos and showed to overlap with the regions of increased apoptosis. Levels of activated (phosphorylated) PKCalpha , beta2, and delta were increased in the embryos of diabetic dams whereas those of PKCepsilon and zeta were decreased when compared with those in control groups. Cytosolic phospholipase A(2) (cPLA(2)) was also activated. Blocking the activity of PKCalpha , beta2, and delta using isoform-specific inhibitors in embryos cultured in hyperglycemia (40 mM) reduced malformation rates when compared with those in untreated hyperglycemic and euglycemic (8.3 mM) groups. These observations demonstrate that PKCalpha, beta2, and delta play an essential role in diabetic embryopathy. Activation of cPLA(2) was also decreased, suggesting that PKCs mediate the hyperglycemic effects through the cPLA(2)-phospholipid peroxidation pathway.
Assuntos
Doenças Fetais/enzimologia , Hiperglicemia/complicações , Defeitos do Tubo Neural/enzimologia , Tubo Neural/enzimologia , Fosfolipases A2 Citosólicas/metabolismo , Proteína Quinase C/metabolismo , Animais , Apoptose/fisiologia , Western Blotting , Diabetes Mellitus Experimental , Técnicas de Cultura Embrionária , Desenvolvimento Embrionário/fisiologia , Feminino , Doenças Fetais/etiologia , Doenças Fetais/prevenção & controle , Masculino , Tubo Neural/efeitos dos fármacos , Tubo Neural/embriologia , Defeitos do Tubo Neural/embriologia , Defeitos do Tubo Neural/prevenção & controle , Fosfolipases A2 Citosólicas/fisiologia , Fosforilação , Gravidez , Isoformas de Proteínas , Proteína Quinase C/antagonistas & inibidores , Inibidores de Proteínas Quinases/farmacologia , Ratos , Ratos Sprague-Dawley , Transdução de Sinais/fisiologia , Saco Vitelino/embriologia , Saco Vitelino/enzimologiaRESUMO
Because of a switch in energy-producing substrate utilization from glucose in the fetal period to fatty acids postnatally, intrauterine morbidity of fatty acid oxidation defects has widely been denied. We report the intrauterine development of severe cardiomyopathy in a child with mitochondrial trifunctional protein deficiency after 27 weeks of gestation. The child was born at 31 weeks of gestation and died on day 3 of life. Severe cardiac mitochondrial proliferation was observed. Molecular analysis of both TFP genes was performed and confirmed a homozygous mutation in the TFP alpha-subunit introducing a stop codon at amino acid position 256 (g.871C>T, p.R256X). Despite severe intrauterine decompensation in our patient, no HELLP-syndrome or acute fatty liver of pregnancy was observed in the mother. In the pathogenesis of maternal HELLP-syndrome, toxic effects of accumulating long-chain hydroxy-acyl-CoAs or long-chain hydroxy-acylcarnitines are suspected. In our patient, acylcarnitine analysis on day 2 of life during severest metabolic decompensation did not reveal massive accumulation of long-chain hydroxy-acylcarnitines in blood, suggesting other pathogenic factors than toxic effects. The most important pathogenic mechanism for the development of intrauterine cardiomyopathy appears to be significant cardiac energy deficiency. In conclusion, our report implicates that fatty acid oxidation does play a significant role during intrauterine development with special regard to the heart. Severe cardiac mitochondrial proliferation in TFP deficiency suggests pathophysiologically relevant energy deficiency in this condition.
Assuntos
Cardiomiopatias/fisiopatologia , Proliferação de Células , Mitocôndrias/fisiologia , Complexos Multienzimáticos/deficiência , Células Musculares/fisiologia , Diagnóstico Pré-Natal , Cardiomiopatias/enzimologia , Cardiomiopatias/genética , Códon sem Sentido , Consanguinidade , Evolução Fatal , Ácidos Graxos/metabolismo , Feminino , Doenças Fetais/enzimologia , Doenças Fetais/genética , Doenças Fetais/fisiopatologia , Humanos , Recém-Nascido , Erros Inatos do Metabolismo/enzimologia , Erros Inatos do Metabolismo/genética , Erros Inatos do Metabolismo/patologia , Erros Inatos do Metabolismo/fisiopatologia , Mitocôndrias/enzimologia , Mitocôndrias/genética , Proteína Mitocondrial Trifuncional , Complexos Multienzimáticos/genética , Células Musculares/citologia , Células Musculares/enzimologia , Células Musculares/patologia , Oxirredução , GravidezRESUMO
Intrauterine inflammation has been implicated in developmental brain injuries, including the development of periventricular leukomalacia (PVL) and cerebral palsy (CP). Previous studies in our rat model of intrauterine inflammation demonstrated apoptotic cell death in fetal brains within the first 5 days after lipopolysaccharide (LPS) administration to mothers and eventual dysmyelination. Cysteine-containing, aspartate-specific proteases, or caspases, are proteins involved with apoptosis through both intracellular (intrinsic pathway) and extracellular (extrinsic pathway) mechanisms. We hypothesized that cell death in our model would occur mainly via activation of the extrinsic pathway. We further hypothesized that Fas, a member of the tumor necrosis factor receptor (TNFR) superfamily, would be increased and the death inducing signaling complex (DISC) would be detectable. Pregnant rats were injected intracervically with LPS at E15 and immunoblotting, immunohistochemical and immunoprecipitation analyses were performed. The presence of the activated form of the effector caspase (caspase-3) was observed 24 h after LPS administration. Caspase activity assays demonstrated rapid increases in (i) caspases-9 and -10 within 1 h, (ii) caspase-8 at 2 h and (iii) caspase-3 at 4 h. At 24 h after LPS, activated caspase-3(+)/Fas(+) cells were observed within the developing white matter. Lastly, the DISC complex (caspase-8, Fas and Fas-associated death domain (FADD)) was observed within 30 min by immunoprecipitation. Apoptosis in our model occurs via both extrinsic and intrinsic pathways, and activation of Fas may play a role. Understanding the mechanisms of cell death in models of intrauterine inflammation may affect development of future strategies to mitigate these injuries in children.
Assuntos
Apoptose , Caspases/metabolismo , Encefalite/enzimologia , Doenças Fetais/enzimologia , Degeneração Neural/enzimologia , Receptor fas/metabolismo , Animais , Paralisia Cerebral/enzimologia , Paralisia Cerebral/etiologia , Paralisia Cerebral/fisiopatologia , Proteínas Adaptadoras de Sinalização de Receptores de Domínio de Morte/metabolismo , Modelos Animais de Doenças , Encefalite/induzido quimicamente , Encefalite/patologia , Ativação Enzimática , Proteína de Domínio de Morte Associada a Fas/metabolismo , Feminino , Doenças Fetais/induzido quimicamente , Doenças Fetais/patologia , Humanos , Recém-Nascido , Mediadores da Inflamação , Isoenzimas/metabolismo , Leucomalácia Periventricular/enzimologia , Leucomalácia Periventricular/etiologia , Leucomalácia Periventricular/fisiopatologia , Lipopolissacarídeos , Degeneração Neural/induzido quimicamente , Degeneração Neural/etiologia , Gravidez , Ratos , Transdução de SinaisRESUMO
In 30- and 90-day-old rats, using immunohistochemistry for glutamic acid decarboxylase 67 (GAD-67), we have tested whether malnutrition during different periods of hippocampal development produces deleterious effects on the population of GABA neurons in the dentate gyrus (DG) and cornu Ammonis (CA1-3) of the dorsal hippocampus. Animals were under one of four nutritional conditions: well-nourished controls (Con), prenatal protein malnourished (PreM), postnatal protein malnourished (PostM), and chronic protein malnourished (ChroM). We found that the number of GAD-67-positive (GAD-67+) interneurons was higher in the DG than in the CA1-3 areas of both Con and malnourished groups. Regarding the DG, the number of GAD-67+ interneurons was increased in PreM and PostM and decreased in ChroM at 30 days. At 90 days of age the number of GAD-67+ interneurons was increased in PostM and ChroM and remained unchanged in PreM. With respect to CA1-3, the number of labeled interneurons was decreased in PostM and ChroM at 30 days of age, but no change was found in PreM. At 90 days no changes in the number of these interneurons were found in any of the groups. These observations suggest that 1) the cell death program starting point is delayed in DG GAD-67+ interneurons, and 2) protein malnutrition differentially affects GAD-67+ interneuron development throughout the dorsal hippocampus. Thus, these changes in the number of GAD-67+ interneurons may partly explain the alterations in modulation of dentate granule cell excitability, as well as in the emotional, motivational, and memory disturbances commonly observed in malnourished rats.